Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials

Peritoneal metastasis is associated with poor prognosis, with studies in the literature reporting the survival of peritoneal metastasis without treatment to be three to six months. Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown positive outcomes by improving the prognosis in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominic, Jerry Lorren, Kannan, Amudhan, Tara, Anjli, Hakim Mohammed, Abdul Rub, Win, Myat, Khorochkov, Arseni, Sultan, Waleed, Ahmed, Asma, Kantamaneni, Ketan, Syzmanski, Michael W., Singh, Rajbir, Marquez, Raul A., Asarian, Armand, Thirunavukarasu, Pragatheeshwar, Keckeisen, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495114/
https://www.ncbi.nlm.nih.gov/pubmed/34650387
http://dx.doi.org/10.17179/excli2021-4108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495114/
https://www.ncbi.nlm.nih.gov/pubmed/34650387
http://dx.doi.org/10.17179/excli2021-4108

Ejemplares similares